PharmaNutra SpA (IT:PHN) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
PharmaNutra S.p.A. has achieved significant sales growth in China for its SiderAL® brand products, surpassing €1 million in sales through major cross-border e-commerce platforms like TMall Global and Douyin. The success in 2024 has prompted the company to accelerate the introduction of its Apportal® line, aiming to replicate this successful strategy. This expansion reflects the growing demand for high-quality nutritional supplements in the Chinese market.
For further insights into IT:PHN stock, check out TipRanks’ Stock Analysis page.
